| 发明名称 |
Modulation of KCNQ potassium channel activity for treatment of psychiatric disorders and the symptoms thereof |
| 摘要 |
Disclosed herein are compositions and methods for treating a psychiatric disorder or symptoms thereof in a patient. The compositions comprise a compound that modulates KCNQ (Kv7) potassium channel activity and the methods include administering an effective amount of the compound that modulates KCNQ (Kv7) potassium channel activity. |
| 申请公布号 |
AU2010256541(B2) |
申请公布日期 |
2016.03.10 |
| 申请号 |
AU20100256541 |
申请日期 |
2010.06.03 |
| 申请人 |
MARQUETTE UNIVERSITY |
发明人 |
GHASEMZADEH, MOHAMMAD HOSSEIN BEHNAM |
| 分类号 |
A61K31/4427;A61K31/122;A61K31/4025;A61K31/4725;A61P25/00;A61P25/18 |
主分类号 |
A61K31/4427 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
